GNLX CIK: 1231457

GENELUX Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
1.89
FY23:
24.2
FY24:
31.5
FY25:
15.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
3.64
FY23:
3.69
FY24:
3.17
FY25:
3.90
Total assets
Change from FY22 to FY25
millions USD
FY22:
5.53
FY23:
27.9
FY24:
34.7
FY25:
19.0

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
31.6
FY23:
6.55
FY24:
6.90
FY25:
6.23
(negative)
Change from FY22 to FY25
millions USD
FY22:
9.69
FY23:
1.87
FY24:
1.54
FY25:
1.26
(positive)
Change from FY22 to FY25
millions USD
FY22:
−35.8
FY23:
19.5
FY24:
26.3
FY25:
11.5
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
5.53
FY23:
27.9
FY24:
34.7
FY25:
19.0

All amounts in millions USD Data source:SEC EDGAR